Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.34 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.34 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16351489 | 0.89 | RAPGEF4 (0.43) | CES2IDO1MAPTRAPGEF4RXRA | |
| SCHEMBL2879502 | 0.84 | CES2 (0.41) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL17448589 | 0.82 | CES2 (0.39) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL383565 | 0.78 | CES2 (0.44) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL3025058 | 0.77 | CES2 (0.48) | CES2IDO1TSHRALDH1A1TDP1 | |
| SCHEMBL440959 | 0.76 | CES2 (0.58) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL16861287 | 0.76 | CES2 (0.42) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL10271930 | 0.76 | CES2 (0.42) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL16823330 | 0.76 | CES2 (0.42) | CES2IDO1TSHRALDH1A1CYP3A4 | |
| SCHEMBL15329899 | 0.76 | CES2 (0.42) | CES2IDO1TSHRALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-20260116900-A1 | PHOSPHINE-PHENOL TRANSITION METAL COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2026-04-30 | — | — | US | disclosed |
| EP-4707283-A1 | TETRAHYDRONAPHTHOL-PHOSPHINE PRE-TRANSITION METAL COMPLEX, AND PREPARATION METHOD THEREFOR AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2026-03-11 | — | — | EP | disclosed |
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | BHATTACHARYA SHRABANTI (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4603493-A1 | PHOSPHINE-PHENOL TRANSITION METAL COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-08-20 | — | — | EP | disclosed |
| CN-119998255-A | Catalytic carboxycarbonylation of olefins to form anhydrides | 北卡罗来纳大学教堂山分校 | 2025-05-13 | — | — | CN | disclosed |
| EP-4543841-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | The University of North Carolina at Chapel Hill (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119661749-A | Coordination precipitation polymerization process for olefin polymerization and polyolefin | 中国石油化工股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119661750-A | Coordination precipitation polymerization process for olefin polymerization and polyolefin | 中国石油化工股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-5574171-A | OF VINYL COMPOUNDS TO PRODUCE 2-SUBSTITUTED 1-PROPANALS, A METAL COMPLEX OF A DIPHOSPHINOGLUCOPYRANOSIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-12 | — | — | US | disclosed |
| US-5510470-A | CONTAINS A DIDEOXYSACCHARIDE; USED WITH ZERO VALENT NICKEL AS A CATALYST FOR ENANTIOSELECTIVE HYDROCYANATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510507-A | COORDINATION CATALYSTS; EFFICIENT ENANTIOSELECTIVITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5484902-A | HYDROCYANATION OF VINYL AROMATICS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-16 | — | — | US | disclosed |
| US-5481006-A | PREPARATION OF INTERMEDIATES FOR PHARMACEUTICALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-02 | — | — | US | disclosed |
| US-5475146-A | Reacting vinyl compound with carbon monoxide and hydrogen in presence of catalyst containing cobalt, rhodium, platinum and/or iridium and chiral carbohydrate phosphorus ligand substituted with electron withdrawing groups | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1995006627-A1 | ENANTIOSELECTIVE HYDROFORMYLATION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-03-09 | — | — | WO | disclosed |
| US-5312957-A | 2-/6-Methoxy-2-naphthalene/propionitrile | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-05-17 | — | — | US | disclosed |
| US-5175335-A | Reacting vinyl aryl compounds with a source of hydrocyanic acid in presence of nickle zero valent compound and nonracemic bidentate organophosphorus ligand | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | CA4, CA12, CA14 | CES2 654/4885IDO1 851/4885TSHR 4615/4885 |
| US-20260116900-A1 | PHOSPHINE-PHENOL TRANSITION METAL COMPLEX, PREPARATION METHOD THEREFOR, AND USE THEREOF | WEE1, WEE2, CYP4F11 | CES2 3464/4885IDO1 691/4885TSHR 1985/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | CES2 4564/4885IDO1 3857/4885TSHR 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.